Prognostic Value of Plasma Markers of Immune Activation in Patients with Advanced HIV Disease Treated by Combination Antiretroviral Therapy

This publication has 23 references indexed in Scilit:

• Tumor Necrosis Factor (TNF) System Levels in Human Immunodeficiency Virus–Infected Patients during Highly Active Antiretroviral Therapy: Persistent TNF Activation Is Associated with Virologic and Immunologic Treatment Failure
  The Journal of Infectious Diseases, 1999
• Serum HIV–1 RNA Levels Compared to Soluble Markers of Immune Activation to Predict Disease Progression in HIV–1–Infected Individuals
  International Archives of Allergy and Immunology, 1998
• Relationship of Plasma HIV-RNA Levels and Levels of TNF-α and Immune Activation Products in HIV Infection
  Clinical Immunology and Immunopathology, 1997
• Increased Soluble Tumor Necrosis Factor Receptor Expression and Release by Human Immunodeficiency Virus Type 1 Infection
  Journal of Interferon & Cytokine Research, 1995
• Serum Levels of Tumor Necrosis Factor- (TNF ) and Soluble TNF Receptors in Human Immunodeficiency Virus Type 1 Infection-Correlations to Clinical, Immunologic, and Virologic Parameters
  The Journal of Infectious Diseases, 1994
• Serum β2-microglobulin and prediction of progression to AIDS in HIV infection
  The Lancet, 1992
• Immunological and serological markers predictive of progression to AIDS in a cohort of HIV-infected drug users
  AIDS, 1990
• Serum beta2-microglobulin level increases in HIV infection
  AIDS, 1990
• The Prognostic Value of Cellular and Serologic Markers in Infection with Human Immunodeficiency Virus Type 1
  New England Journal of Medicine, 1990
• Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort
  BMJ, 1988